Immediate Impact

40 standout
Sub-graph 1 of 19

Citing Papers

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient Care
2024 Standout
3 intermediate papers

Works of André Sarmento‐Cabral being referenced

Hepatocyte-Specific Loss of PPARγ Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver
2021
GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner
2020

Author Peers

Author Last Decade Papers Cites
André Sarmento‐Cabral 192 96 120 22 357
Mercedes del Río-Moreno 239 81 93 19 380
Weiheng Wen 156 103 56 14 350
Yuzhen Liang 111 125 98 29 395
Kristen M. Westfall 174 55 87 24 387
M. R. S. Rao 194 54 95 18 410
Shunkui Luo 120 67 135 15 309
Huili Lin 147 30 50 23 409
W. Mak 168 113 48 19 404
Annett Hoffmann 126 80 119 32 393
P Chowdhury 151 43 62 18 340

All Works

Loading papers...

Rankless by CCL
2026